BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17725468)

  • 1. [Automatic implantable cardioverter defibrillator in hemodialysis patients].
    García García P; González Cabrera F; Jarque A; Navarro JF
    Nefrologia; 2007; 27(3):395-6. PubMed ID: 17725468
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantation of an implantable cardioverter-defibrillator in a patient on chronic hemodialysis.
    Pürerfellner H; Nesser HJ; Aichinger J; Stummvoll K; Steinbach K
    Clin Nephrol; 1993 Feb; 39(2):112-3. PubMed ID: 8448914
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator and mortality in dialysis patients.
    Saravanan P; Davidson NC
    Am J Cardiol; 2009 Jun; 103(11):1623-4. PubMed ID: 19463528
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arrhythmia and conduction abnormalities in hemodialysis patients].
    Ishikawa Y
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():237-45. PubMed ID: 15250301
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantation of a cardioverter defibrillator on the side of a hemodialysis fistula to prevent loss of the alternative arterio-venous access.
    Erdoğan A; Akçay B; Lüdemann M; Spiegl T; Tillmanns H
    Anadolu Kardiyol Derg; 2008 Apr; 8(2):163-4. PubMed ID: 18400639
    [No Abstract]   [Full Text] [Related]  

  • 6. Venous Hemodialysis Catheters and Cardiac Implantable Electronic Devices: Avoiding a High-Risk Combination.
    Saad TF; Weiner HL
    Semin Dial; 2017 May; 30(3):187-192. PubMed ID: 28229483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Don't forget the defibrillator in the dialysis unit.
    Herzog CA
    Nephrol Dial Transplant; 2004 Dec; 19(12):2959-60. PubMed ID: 15574994
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects and pharmacokinetics of mexiletine in ventricular arrhythmia in maintenance hemodialysis patients].
    Kuno T; Takahashi S; Hibiya K; Shimada A; Nagura Y; Takeuchi M; Hatano M
    Nihon Jinzo Gakkai Shi; 1987 Aug; 29(8):1087-92. PubMed ID: 3694885
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantation of cardioverter defibrillator in post-myocardial infarction patients: when and how?
    Efthimiadis GK; Mezilis NE; Styliadis IH
    Eur Heart J; 2007 Oct; 28(19):2416. PubMed ID: 17656348
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of interventions aiming at reducing sudden cardiac death in dialysis patients.
    de Bie MK; van Dam B; Gaasbeek A; van Buren M; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
    Eur Heart J; 2009 Jul; 30(13):1559-64. PubMed ID: 19465437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice.
    Saad TF; Hentschel DM; Koplan B; Wasse H; Asif A; Patel DV; Salman L; Carrillo R; Hoggard J;
    Semin Dial; 2013; 26(1):114-23. PubMed ID: 22891983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive therapy in the setting of implantable cardioverter-defibrillators.
    Davis A; Zisselman M; Simmons T; McCall WV; McCafferty J; Rosenquist PB
    J ECT; 2009 Sep; 25(3):198-201. PubMed ID: 19300291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator.
    Sakhuja R; Keebler M; Lai TS; McLaughlin Gavin C; Thakur R; Bhatt DL
    Am J Cardiol; 2009 Mar; 103(5):735-41. PubMed ID: 19231344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic implantable cardioverter defibrillator in electroconvulsive therapy.
    Bryson EO; Popeo DM; Briggs MC; Pasculli RM; Kellner CH
    J ECT; 2015 Mar; 31(1):e22. PubMed ID: 25148111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implantable cardioverter defibrillator.
    Coltorti F; Senatore C; Marrazzo N; Franciosa P; Nocerino P; Solimene F; D'Isa S; Galizia GL; Chiariello M
    Rev Port Cardiol; 1998 Nov; 17 Suppl 3():III23-6. PubMed ID: 9857742
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiac complications of chronic kidney failure in hemodialysis patients].
    Rautenbach HH
    Curationis; 1979 Sep; 2(2):40-3. PubMed ID: 259480
    [No Abstract]   [Full Text] [Related]  

  • 18. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraoperative hypothermia increased defibrillation energy requirements.
    Kapetanopoulos A; Katsetos MC; Kluger J
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):741-3. PubMed ID: 17700410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we afford implantable cardioverter defibrillator therapy?
    Camm AJ
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):59. PubMed ID: 16265354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.